Overview

DFN-02 Open Label Safety Study in Patients With Acute Migraine

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
A multi-center, open-label, safety study of DFN-02 for the Treatment of Acute Migraines
Phase:
Phase 3
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited